Furthermore, decreased UBE2J1 expression was correlated with unfavorable clinicopathology as well as prognosis, which may provide a meritorious biomarker to predict the diagnosis and prognosis of CRC patients. Here, UBE2J1 is linked to colorectal carcinoma.